Dina Company Overview
Dina is a healthcare technology company focused on improving care coordination with an emphasis on home-based care. The company has developed a platform that streamlines network management, benefit coordination, and transitions of care, aiming to reduce costly healthcare events such as readmissions and avoidable hospitalizations. Dina's technology leverages proprietary algorithms and data sources to identify individuals in need of lower-cost care services, and their solutions are designed to increase coordination efficiency and automate benefits workflows. The company has raised $7 million in a Series B funding round led by First Analysis, with participation from Osage Venture Partners and First Trust Capital Partners, LLC.
Dina Valuation History
Dina Stock Price
The stock price of Dina can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming Dina has issued 250 million shares, at the estimated UpMarket valuation of $26.55 million, each share of Dina stock would be worth $0.11.
Buy Dina Stock
If you would like to buy shares in Dina, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss Dina stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Dina as well.
Dina Management
| Name | Position |
|---|---|
| Ashish V. Shah | CEO |
| Tim Coulter | COO |
